PDB Short entry for 4E4N HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-MAR-12 4E4N TITLE JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN JH1, UNP RESIDUES 854-1154; COMPND 5 SYNONYM: JANUS KINASE 1, JAK-1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK1, JAK1A, JAK1B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS O-PHOSPHOTYROSINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.EIGENBROT REVDAT 4 06-DEC-23 4E4N 1 REMARK REVDAT 3 13-SEP-23 4E4N 1 REMARK SEQADV LINK REVDAT 2 11-JUL-12 4E4N 1 JRNL REVDAT 1 30-MAY-12 4E4N 0 JRNL AUTH J.J.KULAGOWSKI,W.BLAIR,R.J.BULL,C.CHANG,G.DESHMUKH,H.J.DYKE, JRNL AUTH 2 C.EIGENBROT,N.GHILARDI,P.GIBBONS,T.K.HARRISON,P.R.HEWITT, JRNL AUTH 3 M.LIIMATTA,C.A.HURLEY,A.JOHNSON,T.JOHNSON,J.R.KENNY, JRNL AUTH 4 P.BIR KOHLI,R.J.MAXEY,R.MENDONCA,K.MORTARA,J.MURRAY, JRNL AUTH 5 R.NARUKULLA,S.SHIA,M.STEFFEK,S.UBHAYAKAR,M.ULTSCH, JRNL AUTH 6 A.VAN ABBEMA,S.I.WARD,B.WASZKOWYCZ,M.ZAK JRNL TITL IDENTIFICATION OF IMIDAZO-PYRROLOPYRIDINES AS NOVEL AND JRNL TITL 2 POTENT JAK1 INHIBITORS. JRNL REF J.MED.CHEM. V. 55 5901 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22591402 JRNL DOI 10.1021/JM300438J REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 47965 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2336 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6615 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 322 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4677 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 294 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.69000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.149 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.141 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.098 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.468 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4834 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3367 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6526 ; 1.171 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8226 ; 0.833 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 569 ; 5.579 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;38.598 ;24.414 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 896 ;12.104 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;17.198 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 697 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5230 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 932 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 944 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3417 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2314 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2361 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 225 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.157 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 52 ; 0.304 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.147 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3017 ; 3.096 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1154 ; 0.630 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4636 ; 3.997 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2144 ; 3.074 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1890 ; 4.595 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 853 A 1160 4 REMARK 3 1 B 853 B 1160 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 3924 ; 0.30 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 3924 ; 0.64 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 853 A 959 REMARK 3 ORIGIN FOR THE GROUP (A): -6.1864 60.1146 -3.4821 REMARK 3 T TENSOR REMARK 3 T11: -0.0159 T22: -0.0500 REMARK 3 T33: 0.0305 T12: -0.0226 REMARK 3 T13: -0.0076 T23: -0.0426 REMARK 3 L TENSOR REMARK 3 L11: 1.3272 L22: 0.2886 REMARK 3 L33: 1.8674 L12: -0.4945 REMARK 3 L13: 1.2592 L23: -0.7341 REMARK 3 S TENSOR REMARK 3 S11: 0.0363 S12: -0.0101 S13: -0.2162 REMARK 3 S21: -0.0881 S22: -0.0071 S23: 0.0925 REMARK 3 S31: 0.0926 S32: 0.0200 S33: -0.0292 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 960 A 1154 REMARK 3 ORIGIN FOR THE GROUP (A): 12.9712 51.2062 16.4574 REMARK 3 T TENSOR REMARK 3 T11: -0.0374 T22: -0.0530 REMARK 3 T33: -0.0006 T12: -0.0217 REMARK 3 T13: 0.0096 T23: -0.0065 REMARK 3 L TENSOR REMARK 3 L11: 1.5236 L22: 0.8482 REMARK 3 L33: 0.7313 L12: 0.1970 REMARK 3 L13: 0.2270 L23: -0.2403 REMARK 3 S TENSOR REMARK 3 S11: 0.0170 S12: -0.0210 S13: -0.1769 REMARK 3 S21: 0.0825 S22: 0.0623 S23: -0.0044 REMARK 3 S31: 0.0059 S32: 0.0000 S33: -0.0794 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 865 B 959 REMARK 3 ORIGIN FOR THE GROUP (A): 24.3482 2.8760 -2.9411 REMARK 3 T TENSOR REMARK 3 T11: -0.0100 T22: -0.0354 REMARK 3 T33: -0.0423 T12: 0.0011 REMARK 3 T13: 0.0166 T23: -0.0111 REMARK 3 L TENSOR REMARK 3 L11: 1.3817 L22: 0.9435 REMARK 3 L33: 1.8214 L12: -0.4006 REMARK 3 L13: -0.3599 L23: 0.0155 REMARK 3 S TENSOR REMARK 3 S11: 0.0795 S12: 0.0228 S13: 0.0154 REMARK 3 S21: -0.2136 S22: -0.0337 S23: -0.1768 REMARK 3 S31: 0.0298 S32: 0.0988 S33: -0.0458 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 960 B 1154 REMARK 3 ORIGIN FOR THE GROUP (A): 8.3374 10.2211 15.9851 REMARK 3 T TENSOR REMARK 3 T11: -0.0384 T22: -0.0294 REMARK 3 T33: -0.0332 T12: -0.0083 REMARK 3 T13: 0.0020 T23: -0.0224 REMARK 3 L TENSOR REMARK 3 L11: 1.3778 L22: 1.2130 REMARK 3 L33: 0.8178 L12: 0.5997 REMARK 3 L13: -0.1776 L23: 0.1585 REMARK 3 S TENSOR REMARK 3 S11: 0.0562 S12: -0.1213 S13: 0.2052 REMARK 3 S21: 0.0778 S22: 0.0255 S23: 0.1846 REMARK 3 S31: -0.0268 S32: 0.0376 S33: -0.0817 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4E4N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1000071163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50322 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2B7A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, PH 5.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 86.61950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 913 REMARK 465 SER A 914 REMARK 465 GLY A 915 REMARK 465 GLY A 916 REMARK 465 ASN A 917 REMARK 465 ASP A 947 REMARK 465 GLY A 948 REMARK 465 GLY A 949 REMARK 465 ASN A 950 REMARK 465 GLY B 853 REMARK 465 ASP B 854 REMARK 465 ILE B 855 REMARK 465 VAL B 856 REMARK 465 SER B 857 REMARK 465 GLU B 858 REMARK 465 LYS B 859 REMARK 465 LYS B 860 REMARK 465 PRO B 861 REMARK 465 ALA B 862 REMARK 465 THR B 863 REMARK 465 GLU B 864 REMARK 465 GLU B 913 REMARK 465 SER B 914 REMARK 465 GLY B 915 REMARK 465 GLY B 916 REMARK 465 GLU B 946 REMARK 465 ASP B 947 REMARK 465 GLY B 948 REMARK 465 GLY B 949 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 862 96.39 -66.51 REMARK 500 ASP A1003 31.63 -148.92 REMARK 500 ASP A1042 48.80 -96.76 REMARK 500 ASP B1003 33.16 -146.89 REMARK 500 ASP B1042 49.17 -107.54 REMARK 500 THR B1095 51.93 -114.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 1408 REMARK 615 HOH B 1389 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0NL A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0NL B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4E4L RELATED DB: PDB REMARK 900 RELATED ID: 4E4M RELATED DB: PDB REMARK 900 RELATED ID: 4E5W RELATED DB: PDB REMARK 900 RELATED ID: 4E6D RELATED DB: PDB REMARK 900 RELATED ID: 4E6Q RELATED DB: PDB DBREF 4E4N A 854 1154 UNP P23458 JAK1_HUMAN 854 1154 DBREF 4E4N B 854 1154 UNP P23458 JAK1_HUMAN 854 1154 SEQADV 4E4N GLY A 853 UNP P23458 EXPRESSION TAG SEQADV 4E4N GLY B 853 UNP P23458 EXPRESSION TAG SEQRES 1 A 302 GLY ASP ILE VAL SER GLU LYS LYS PRO ALA THR GLU VAL SEQRES 2 A 302 ASP PRO THR HIS PHE GLU LYS ARG PHE LEU LYS ARG ILE SEQRES 3 A 302 ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS VAL GLU LEU SEQRES 4 A 302 CYS ARG TYR ASP PRO GLU GLY ASP ASN THR GLY GLU GLN SEQRES 5 A 302 VAL ALA VAL LYS SER LEU LYS PRO GLU SER GLY GLY ASN SEQRES 6 A 302 HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU ILE LEU ARG SEQRES 7 A 302 ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR LYS GLY ILE SEQRES 8 A 302 CYS THR GLU ASP GLY GLY ASN GLY ILE LYS LEU ILE MET SEQRES 9 A 302 GLU PHE LEU PRO SER GLY SER LEU LYS GLU TYR LEU PRO SEQRES 10 A 302 LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN GLN LEU LYS SEQRES 11 A 302 TYR ALA VAL GLN ILE CYS LYS GLY MET ASP TYR LEU GLY SEQRES 12 A 302 SER ARG GLN TYR VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 13 A 302 VAL LEU VAL GLU SER GLU HIS GLN VAL LYS ILE GLY ASP SEQRES 14 A 302 PHE GLY LEU THR LYS ALA ILE GLU THR ASP LYS GLU PTR SEQRES 15 A 302 PTR THR VAL LYS ASP ASP ARG ASP SER PRO VAL PHE TRP SEQRES 16 A 302 TYR ALA PRO GLU CYS LEU MET GLN SER LYS PHE TYR ILE SEQRES 17 A 302 ALA SER ASP VAL TRP SER PHE GLY VAL THR LEU HIS GLU SEQRES 18 A 302 LEU LEU THR TYR CYS ASP SER ASP SER SER PRO MET ALA SEQRES 19 A 302 LEU PHE LEU LYS MET ILE GLY PRO THR HIS GLY GLN MET SEQRES 20 A 302 THR VAL THR ARG LEU VAL ASN THR LEU LYS GLU GLY LYS SEQRES 21 A 302 ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP GLU VAL TYR SEQRES 22 A 302 GLN LEU MET ARG LYS CYS TRP GLU PHE GLN PRO SER ASN SEQRES 23 A 302 ARG THR SER PHE GLN ASN LEU ILE GLU GLY PHE GLU ALA SEQRES 24 A 302 LEU LEU LYS SEQRES 1 B 302 GLY ASP ILE VAL SER GLU LYS LYS PRO ALA THR GLU VAL SEQRES 2 B 302 ASP PRO THR HIS PHE GLU LYS ARG PHE LEU LYS ARG ILE SEQRES 3 B 302 ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS VAL GLU LEU SEQRES 4 B 302 CYS ARG TYR ASP PRO GLU GLY ASP ASN THR GLY GLU GLN SEQRES 5 B 302 VAL ALA VAL LYS SER LEU LYS PRO GLU SER GLY GLY ASN SEQRES 6 B 302 HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU ILE LEU ARG SEQRES 7 B 302 ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR LYS GLY ILE SEQRES 8 B 302 CYS THR GLU ASP GLY GLY ASN GLY ILE LYS LEU ILE MET SEQRES 9 B 302 GLU PHE LEU PRO SER GLY SER LEU LYS GLU TYR LEU PRO SEQRES 10 B 302 LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN GLN LEU LYS SEQRES 11 B 302 TYR ALA VAL GLN ILE CYS LYS GLY MET ASP TYR LEU GLY SEQRES 12 B 302 SER ARG GLN TYR VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 13 B 302 VAL LEU VAL GLU SER GLU HIS GLN VAL LYS ILE GLY ASP SEQRES 14 B 302 PHE GLY LEU THR LYS ALA ILE GLU THR ASP LYS GLU PTR SEQRES 15 B 302 PTR THR VAL LYS ASP ASP ARG ASP SER PRO VAL PHE TRP SEQRES 16 B 302 TYR ALA PRO GLU CYS LEU MET GLN SER LYS PHE TYR ILE SEQRES 17 B 302 ALA SER ASP VAL TRP SER PHE GLY VAL THR LEU HIS GLU SEQRES 18 B 302 LEU LEU THR TYR CYS ASP SER ASP SER SER PRO MET ALA SEQRES 19 B 302 LEU PHE LEU LYS MET ILE GLY PRO THR HIS GLY GLN MET SEQRES 20 B 302 THR VAL THR ARG LEU VAL ASN THR LEU LYS GLU GLY LYS SEQRES 21 B 302 ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP GLU VAL TYR SEQRES 22 B 302 GLN LEU MET ARG LYS CYS TRP GLU PHE GLN PRO SER ASN SEQRES 23 B 302 ARG THR SER PHE GLN ASN LEU ILE GLU GLY PHE GLU ALA SEQRES 24 B 302 LEU LEU LYS MODRES 4E4N PTR A 1034 TYR O-PHOSPHOTYROSINE MODRES 4E4N PTR A 1035 TYR O-PHOSPHOTYROSINE MODRES 4E4N PTR B 1034 TYR O-PHOSPHOTYROSINE MODRES 4E4N PTR B 1035 TYR O-PHOSPHOTYROSINE HET PTR A1034 16 HET PTR A1035 16 HET PTR B1034 16 HET PTR B1035 16 HET 0NL A1201 25 HET 0NL B1201 25 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 0NL TERT-BUTYL [(1R,3R)-3-(IMIDAZO[4,5-D]PYRROLO[2,3- HETNAM 2 0NL B]PYRIDIN-1(6H)-YL)CYCLOPENTYL]CARBAMATE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 0NL 2(C18 H23 N5 O2) FORMUL 5 HOH *294(H2 O) HELIX 1 1 GLU A 871 ARG A 873 5 3 HELIX 2 2 ILE A 919 ASN A 931 1 13 HELIX 3 3 SER A 963 ASN A 971 1 9 HELIX 4 4 ASN A 976 ARG A 997 1 22 HELIX 5 5 ALA A 1005 ARG A 1007 5 3 HELIX 6 6 PRO A 1044 TYR A 1048 5 5 HELIX 7 7 ALA A 1049 SER A 1056 1 8 HELIX 8 8 ILE A 1060 THR A 1076 1 17 HELIX 9 9 ASP A 1079 SER A 1082 5 4 HELIX 10 10 SER A 1083 GLY A 1093 1 11 HELIX 11 11 HIS A 1096 GLN A 1098 5 3 HELIX 12 12 MET A 1099 GLU A 1110 1 12 HELIX 13 13 PRO A 1121 CYS A 1131 1 11 HELIX 14 14 GLN A 1135 ARG A 1139 5 5 HELIX 15 15 SER A 1141 LYS A 1154 1 14 HELIX 16 16 GLU B 871 ARG B 873 5 3 HELIX 17 17 HIS B 918 ASN B 931 1 14 HELIX 18 18 SER B 963 ASN B 971 1 9 HELIX 19 19 ASN B 976 ARG B 997 1 22 HELIX 20 20 ALA B 1005 ARG B 1007 5 3 HELIX 21 21 PRO B 1044 TYR B 1048 5 5 HELIX 22 22 ALA B 1049 SER B 1056 1 8 HELIX 23 23 ILE B 1060 THR B 1076 1 17 HELIX 24 24 ASP B 1079 SER B 1082 5 4 HELIX 25 25 SER B 1083 GLY B 1093 1 11 HELIX 26 26 HIS B 1096 GLN B 1098 5 3 HELIX 27 27 MET B 1099 GLU B 1110 1 12 HELIX 28 28 PRO B 1121 CYS B 1131 1 11 HELIX 29 29 GLN B 1135 ARG B 1139 5 5 HELIX 30 30 SER B 1141 LYS B 1154 1 14 SHEET 1 A 5 LEU A 875 GLU A 883 0 SHEET 2 A 5 GLY A 887 TYR A 894 -1 O LEU A 891 N ARG A 879 SHEET 3 A 5 GLU A 903 LEU A 910 -1 O GLU A 903 N TYR A 894 SHEET 4 A 5 LYS A 953 GLU A 957 -1 O MET A 956 N ALA A 906 SHEET 5 A 5 TYR A 940 CYS A 944 -1 N GLY A 942 O ILE A 955 SHEET 1 B 2 TYR A 999 VAL A1000 0 SHEET 2 B 2 LYS A1026 ALA A1027 -1 O LYS A1026 N VAL A1000 SHEET 1 C 2 VAL A1009 SER A1013 0 SHEET 2 C 2 GLN A1016 ILE A1019 -1 O LYS A1018 N LEU A1010 SHEET 1 D 2 PTR A1034 THR A1036 0 SHEET 2 D 2 LYS A1057 TYR A1059 -1 O PHE A1058 N PTR A1035 SHEET 1 E 5 LEU B 875 GLU B 883 0 SHEET 2 E 5 GLY B 887 TYR B 894 -1 O LEU B 891 N ILE B 878 SHEET 3 E 5 GLU B 903 LEU B 910 -1 O GLU B 903 N TYR B 894 SHEET 4 E 5 LYS B 953 GLU B 957 -1 O MET B 956 N ALA B 906 SHEET 5 E 5 TYR B 940 CYS B 944 -1 N GLY B 942 O ILE B 955 SHEET 1 F 2 TYR B 999 VAL B1000 0 SHEET 2 F 2 LYS B1026 ALA B1027 -1 O LYS B1026 N VAL B1000 SHEET 1 G 2 VAL B1009 SER B1013 0 SHEET 2 G 2 GLN B1016 ILE B1019 -1 O LYS B1018 N LEU B1010 SHEET 1 H 2 PTR B1034 THR B1036 0 SHEET 2 H 2 LYS B1057 TYR B1059 -1 O PHE B1058 N PTR B1035 LINK C GLU A1033 N PTR A1034 1555 1555 1.33 LINK C PTR A1034 N PTR A1035 1555 1555 1.33 LINK C PTR A1035 N THR A1036 1555 1555 1.33 LINK C GLU B1033 N PTR B1034 1555 1555 1.33 LINK C PTR B1034 N PTR B1035 1555 1555 1.33 LINK C PTR B1035 N THR B1036 1555 1555 1.34 SITE 1 AC1 16 GLY A 882 GLU A 883 GLY A 887 LYS A 888 SITE 2 AC1 16 VAL A 889 ALA A 906 LYS A 908 MET A 956 SITE 3 AC1 16 GLU A 957 PHE A 958 LEU A 959 ASN A1008 SITE 4 AC1 16 LEU A1010 GLY A1020 ASP A1021 HOH A1393 SITE 1 AC2 15 GLY B 882 GLU B 883 GLY B 884 GLY B 887 SITE 2 AC2 15 VAL B 889 ALA B 906 LYS B 908 GLU B 957 SITE 3 AC2 15 PHE B 958 LEU B 959 ASN B1008 LEU B1010 SITE 4 AC2 15 ASP B1021 HOH B1315 HOH B1447 CRYST1 42.640 173.239 44.799 90.00 94.22 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023452 0.000000 0.001730 0.00000 SCALE2 0.000000 0.005772 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022383 0.00000